Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Protein glycosylation is an important posttranslational process, which regulates protein folding and functional expression. Studies have shown that abnormal glycosylation in tumor cells affects cancer progression and malignancy. In the current study, we have identified sialylated proteins using an alkynyl sugar probe in two different lung cancer cell lines, CL1-0 and CL1-5 with distinct invasiveness derived from the same parental cell line. Among the identified sialylated proteins, epidermal growth factor receptor (EGFR) was chosen to understand the effect of sialylation on its function. We have determined the differences in glycan sequences of EGFR in both cells and observed higher sialylation and fucosylation of EGFR in CL1-5 than in CL1-0. Further study suggested that overexpression of sialyltransferases in CL1-5 and α1,3-fucosyltransferases (FUT4 or FUT6) in CL1-5 and A549 cells would suppress EGFR dimerization and phosphorylation upon EGF treatment, as compared to the control and CL1-0 cells. Such modulating effects on EGFR dimerization were further confirmed by sialidase or fucosidase treatment. Thus, increasing sialylation and fucosylation could attenuate EGFR-mediated invasion of lung cancer cells. However, incorporation of the core fucose by α1,6-fucosylatransferase (FUT8) would promote EGFR dimerization and phosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a similar vein, both sialylation and fucosylation modulate epidermal growth factor receptor-mediated intracellular signaling (528 -530).”
From Biological roles of glycans (2017) · cites this paper as [529]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774 · cited 1×
“It belongs to the EGFR family and transduces cell signaling through ligand (EGF)-induced receptor dimerization (4), which then initiates its tyrosine kinase activity to direct the malignant behaviors of cancers (5).”
BackgroundEGF–ERBB signalling: towards the systems level
Citri, A., & Yarden, Y. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1962 · Cited by 2,004 · cited 1×
“After autophosphorylation, dimeric EGFR recruits and activates various downstream signaling proteins to direct cell proliferation, migration, differentiation, and apoptosis (11).”
BackgroundGlycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598 · cited 1×
“In particular, the terminal position of glycans with sugars such as sialic acid and fucose is usually exhibited at a high level in tumor cells (1).”
BackgroundCrystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
β1-6 Branching of Asn-Linked Oligosaccharides Is Directly Associated with Metastasis
Dennis, J. W., Laferté, S., Waghorne, C., Breitman, M. L., & Kerbel, R. S. (1987) · Science · doi:10.1126/science.2953071 · Cited by 940 · cited 1×
“For example, the α1,6-linked fucosylation of complex-type glycans may be an important feature of tumor progression related to increased metastasis (26), overexpression ofN-acetylglucosaminyltransferase V can enhance the invasion ability of glioma cells (27), and overexpression of FUT4 would promote the proliferation o…”
BackgroundMining the plasma proteome for cancer biomarkers
Hanash, S. M., Pitteri, S. J., & Faca, V. M. (2008) · Nature · doi:10.1038/nature06916 · Cited by 891 · cited 2×
“Together with the previous reports that Lex and sLex epitopes were detected in EGFR of A431 cells (13, 25), our results indicated that Lex and sLex could affect EGFR dimerization.”
BackgroundResultEGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain Dimerization
Ferguson, K. M., Berger, M. B., Mendrola, J. M., Cho, H.-S., Leahy, D. J., & Lemmon, M. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00047-9 · Cited by 801 · cited 1×
“In the state without ligand stimulation, an intramolecular interaction between domains II and IV maintains EGFR in a tethered conformation to inhibit dimerization (8), and this conformation is opened up by EGF binding to expose the dimerization interface for receptor activation (9, 10).”
BackgroundCarbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis
Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., & Kimura, N. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03219.x · Cited by 572 · cited 1×
“These two major terminal sugars may participate in important cell–cell interactions and cell migrations in cancer metastasis and angiogenesis (2).”
BackgroundStructure of the Extracellular Region of HER3 Reveals an Interdomain Tether
Cho, H.-S., & Leahy, D. J. (2002) · Science · doi:10.1126/science.1074611 · Cited by 447 · cited 1×
“In the state without ligand stimulation, an intramolecular interaction between domains II and IV maintains EGFR in a tethered conformation to inhibit dimerization (8), and this conformation is opened up by EGF binding to expose the dimerization interface for receptor activation (9, 10).”
BackgroundSelection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line
Chu, Y.-W., Yang, P.-C., Yang, S.-C., Shyu, Y.-C., Hendrix, M. J. C., Wu, R., & Wu, C.-W. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.3.2837 · Cited by 420 · cited 13×
“This sorting system results in two distinct cell populations that express very different sets of proteins, especially those for cancer progression; for example, CL1-5 cells express more MMP-9 (23).”
BackgroundMethodResultInfluentialSelf-citationThe role of the EGFR signaling in tumor microenvironment
De Luca, A., Carotenuto, A., Rachiglio, A., Gallo, M., Maiello, M. R., Aldinucci, D., Pinto, A., & Normanno, N. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21260 · Cited by 359 · cited 1×
“EGFR is overexpressed in various kinds of cancer cells and participates in the regulation of cancer invasion, metastasis, and angiogenesis (3).”
BackgroundCore Fucosylation Regulates Epidermal Growth Factor Receptor-mediated Intracellular Signaling
Wang, X., Gu, J., Ihara, H., Miyoshi, E., Honke, K., & Taniguchi, N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510893200 · Cited by 323 · cited 3×
“Our results were consistent with the report that FUT8 knockout cells are less sensitive to EGF treatment, and this is possibly due to the reduction of EGF-binding affinity when EGFR bears no core fucoses (20).”
BackgroundResultAlkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
Hsu, T.-L., Hanson, S. R., Kishikawa, K., Wang, S.-K., Sawa, M., & Wong, C.-H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611307104 · Cited by 319 · cited 2×
“By employing alkynyl sugars as probes for metabolically labeling and enriching cellular glycoproteins (22, 24), we compared the sialyl glycoproteins expressed on the lung cancer cells CL1-0 and CL15.”
MethodSelf-citationGlycans on influenza hemagglutinin affect receptor binding and immune response
Wang, C.-C., Chen, J.-R., Tseng, Y.-C., Hsu, C.-H., Hung, Y.-F., Chen, S.-W., Chen, C.-M., Khoo, K.-H., Cheng, T.-J., Cheng, Y.-S. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909696106 · Cited by 316 · cited 1×
“In virus infection, it has been observed that removal of glycans on influenza hemagglutinin enhances binding to cell surface receptors (34).”
BackgroundSelf-citationDawson, J. P., Berger, M. B., Lin, C.-C., Schlessinger, J., Lemmon, M. A., & Ferguson, K. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7734-7742.2005 · Cited by 297
Ligand-induced ErbB receptor dimerization
Lemmon, M. A. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.10.024 · Cited by 216 · cited 1×
“It belongs to the EGFR family and transduces cell signaling through ligand (EGF)-induced receptor dimerization (4), which then initiates its tyrosine kinase activity to direct the malignant behaviors of cancers (5).”
BackgroundLax, I., Bellot, F., Howk, R., Ullrich, A., Givol, D., & Schlessinger, J. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03393.x · Cited by 198 · cited 1×
“The extracellular domains of the EGFR family members are divided into four subdomains, with domains I and III participating in ligand binding (6) and domains II and IV for dimerization (7).”
BackgroundYamamoto, H., Swoger, J., Greene, S., SAITO, T., Hurh, J., Sweeley, C., Leestma, J. E., Mkrdichian, E., Cerullo, L. J., Nishikawa, A., et al. (2000) · PubMed · Cited by 151
Characterization of Glycosylation Sites of the Epidermal Growth Factor Receptor
Zhen, Y., Caprioli, R. M., & Staros, J. V. (2003) · Biochemistry · doi:10.1021/bi027101p · Cited by 126 · cited 1×
“Twelve N-linked glycosylation sites were reported to exist in the extracellular region of EGFR (12).”
BackgroundCummings, R. D., Soderquist, A. M., & Carpenter, G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38969-x · Cited by 125 · cited 1×
“Previous studies have reported the fractionation and identification of EGFR glycans in A431 cells and indicated that the blood group A antigen, as exemplified by α-linked terminal N acetylgalactosamine, can be highly expressed in EGFR (36, 37), whereas terminal sialylation and α1,3-fucosylation are limited in A431 cel…”
BackgroundTsuda, T., Ikeda, Y., & Taniguchi, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003400200 · Cited by 116 · cited 3×
“Among these CL1-5 uniquely expressed sialyl proteins (Table S1), EGFR was chosen for further investigation for its important role in promoting tumor growth and metastasis, and the link of EGFR N-linked glycosylation to its function (14, 16, 17).”
BackgroundAlpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo.
Yamamoto, H., Oviedo, A., Sweeley, C., SAITO, T., & Moskal, J. R. (2001) · PubMed · Cited by 107
Tailored Glycoproteomics and Glycan Site Mapping Using Saccharide-Selective Bioorthogonal Probes
Hanson, S. R., Hsu, T.-L., Weerapana, E., Kishikawa, K., Simon, G. M., Cravatt, B. F., & Wong, C.-H. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0724083 · Cited by 101 · cited 1×
“By employing alkynyl sugars as probes for metabolically labeling and enriching cellular glycoproteins (22, 24), we compared the sialyl glycoproteins expressed on the lung cancer cells CL1-0 and CL15.”
MethodSelf-citationMATSUMOTO, K. Y., Yokote, H., Arao, T., Maegawa, M., Tanaka, K., Fujita, Y., Shimizu, C., Hanafusa, T., Fujiwara, Y., & Nishio, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00847.x · Cited by 93 · cited 1×
“Further studies have indicated that overexpressing FUT8 could increase the susceptibility of EGFR to specific tyrosine kinase inhibitors, whereas knockdown of FUT8 decreases the susceptibility (21).”
BackgroundDefize, L. H., Arndt-Jovin, D. J., Jovin, T. M., Boonstra, J., Meisenhelder, J., Hunter, T., de Hey, H. T., & de Laat, S. W. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.3.939 · Cited by 86 · cited 2×
“Previous studies have reported the fractionation and identification of EGFR glycans in A431 cells and indicated that the blood group A antigen, as exemplified by α-linked terminal N acetylgalactosamine, can be highly expressed in EGFR (36, 37), whereas terminal sialylation and α1,3-fucosylation are limited in A431 cel…”
BackgroundKroes, R. A., He, H., Emmett, M. R., Nilsson, C. L., Leach, F. E., Amster, I. J., Marshall, A. G., & Moskal, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909862107 · Cited by 79 · cited 1×
“For instance, α2,6-sialylated glycans may inhibit glioma malignancy because decreased α2,6-sialylation on glycoproteins (29, 30) or on gangliosides (31) enhances glioma formation and invasion; inhibition of N-linked glycosylation by tunicamycin can induce functional E-cadherin-mediated cell–cell adhesion (32); removal…”
BackgroundFunctional Effects of Glycosylation at Asn-579 of the Epidermal Growth Factor Receptor
Whitson, K. B., Whitson, S. R., Red-Brewer, M. L., McCoy, A. J., Vitali, A. A., Walker, F., Johns, T. G., Beth, A. H., & Staros, J. V. (2005) · Biochemistry · doi:10.1021/bi050751j · Cited by 77
Meuillet, E. J., Kroes, R. A., Yamamoto, H., Warner, T. G., Ferrari, J., Mania-Farnell, B. L., George, D., Rebbaa, A., Moskal, J. R., & Bremer, E. G. (1999) · PubMed · Cited by 69
de‐Freitas‐Junior, J. C. M., Rocher, B. D., de Souza, W. F., de Araújo, W. M., Abdelhay, E. S. F. W., & Morgado‐Díaz, J. A. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1477-8 · Cited by 65 · cited 1×
“For instance, α2,6-sialylated glycans may inhibit glioma malignancy because decreased α2,6-sialylation on glycoproteins (29, 30) or on gangliosides (31) enhances glioma formation and invasion; inhibition of N-linked glycosylation by tunicamycin can induce functional E-cadherin-mediated cell–cell adhesion (32); removal…”
BackgroundN-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion
Takahashi, M., Yokoe, S., Asahi, M., Lee, S. H., Li, W., Osumi, D., Miyoshi, E., & Taniguchi, N. (2007) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.10.019 · Cited by 63 · cited 3×
“Some previous studies have indicated that the glycans could participate in regulating certain functions of EGFR (14).”
BackgroundYokoe, S., Takahashi, M., Asahi, M., Lee, S. H., Li, W., Osumi, D., Miyoshi, E., & Taniguchi, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3023 · Cited by 57
Stroop, C. J. M., Weber, W., Gerwig, G. J., Nimtz, M., Kamerling, J. P., & Vliegenthart, J. F. G. (2000) · Glycobiology · doi:10.1093/glycob/10.9.901 · Cited by 56 · cited 1×
“Together with the previous reports that Lex and sLex epitopes were detected in EGFR of A431 cells (13, 25), our results indicated that Lex and sLex could affect EGFR dimerization.”
ResultLi, W., Nakagawa, T., Koyama, N., Wang, X., Jin, J., Mizuno-Horikawa, Y., Gu, J., Miyoshi, E., Kato, I., Honke, K., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl023 · Cited by 46 · cited 1×
“On the other hand, core fucosylation was reported to aid EGFR activation: knocking down fucosyltransferase (FUT) 8 attenuates EGFR phosphorylation (19), and knocking out FUT8 reduces the EGF-binding ability of EGFR and down-regulates EGFR-mediated MAPK signaling (20).”
BackgroundYamamoto, H., Kaneko, Y., Rebbaa, A., Bremer, E. G., & Moskal, J. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062566.x · Cited by 44 · cited 1×
“For instance, α2,6-sialylated glycans may inhibit glioma malignancy because decreased α2,6-sialylation on glycoproteins (29, 30) or on gangliosides (31) enhances glioma formation and invasion; inhibition of N-linked glycosylation by tunicamycin can induce functional E-cadherin-mediated cell–cell adhesion (32); removal…”
BackgroundYang, X., Liu, S., Liu, Y., Liu, J., Liu, T., Wang, X., & Yan, Q. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22250 · Cited by 41
Self-citationLi, J., Cheng, L., Wang, L., Liu, H., Li, L., Wang, X., & Geng, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0548-9 · Cited by 13 · cited 1×
“For instance, α2,6-sialylated glycans may inhibit glioma malignancy because decreased α2,6-sialylation on glycoproteins (29, 30) or on gangliosides (31) enhances glioma formation and invasion; inhibition of N-linked glycosylation by tunicamycin can induce functional E-cadherin-mediated cell–cell adhesion (32); removal…”
Background
Research works printed but not linked: 1
- Whitson KB, et al. Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor. Biochemistry. 2005;44:14920–14931. doi: 10.1021/bi050751j. [[DOI](https://doi.org/10.1021/bi050751j)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/16274239/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Biochemistry&title=Functional%20effects%20of%20glycosylation%20at%20Asn-579%20of%20the%20epidermal%20growth%20factor%20receptor&author=KB%20Whitson&volume=44&publication_year=2005&pages=14920-14931&pmid=16274239&doi=10.1021/bi050751j&)] · DOI · Paper page
Cited by
Glycosylation in cancer: mechanisms and clinical implications
Pinho, S. S., & Reis, C. A. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3982 · Cited by 3,083
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“In a similar vein, both sialylation and fucosylation modulate epidermal growth factor receptor-mediated intracellular signaling (528) (529) (530) .”
BackgroundProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
“In contrast, enhancing the sialylation and fucosylation of N-glycans on the EGFR of various lung cancer cell lines appears to inhibit EGFR dimerization (170), thus inhibiting this important process in the continued survival and progression of some types of lung cancer (171).”
BackgroundCurrent Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
“In contrast, high concentration anionic NPs (zeta potential between 215 and 260 mV) and cationic NPs (zeta potential between 15 and 45 mV) compromise BBB integrity (Lockman et al., 2004).”
BackgroundFinding the Right (Bioorthogonal) Chemistry
Patterson, D. M., Nazarova, L. A., & Prescher, J. A. (2014) · ACS Chemical Biology · doi:10.1021/cb400828a · Cited by 652
Metadata
- Authors
- Liu, Y.-C., Yen, H.-Y., Chen, C.-Y., Chen, C.-H., Cheng, P.-F., Juan, Y.-H., Chen, C.-H., Khoo, K.-H., Yu, C.-J., Yang, P.-C., Hsu, T.-L., & Wong, C.-H.
- Affiliations
- National Taiwan University (TW)
- Institute of Biological Chemistry, Academia Sinica (TW)
- Genomics Research Center, Academia Sinica (TW)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-06-27
- Volume
- 108
- Issue
- 28
- Pages
- 11332-11337
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3136320
- OpenAlex
- W2053429933
- Cited by
- 424
- References
- 38
- Citations by year
- 2026: 20 · 2025: 23 · 2024: 26 · 2023: 28 · 2022: 36 · 2021: 42 · 2020: 36 · 2019: 29 · 2018: 26 · 2017: 27 · 2016: 33 · 2015: 26 · 2014: 28 · 2013: 22 · 2012: 19
- FWCI
- 9.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- epidermal growth factor receptor, sialylation, fucosylation, protein glycosylation, lung cancer, EGFR dimerization, EGFR phosphorylation, tumor invasion, sialyltransferase, alpha-1,3-fucosyltransferase, alpha-1,6-fucosyltransferase, FUT8
- MeSH terms
- Amino Acid Sequence, Base Sequence, Binding Sites, Enzyme Activation, Fucose, Glycosylation, Humans, Lung Neoplasms, Models, Molecular, Molecular Sequence Data, Neoplasm Invasiveness, Recombinant Proteins, Sialic Acids, DNA Primers, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Dimerization, Protein Structure, Quaternary, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.